Holen Sie sich die Stockscreener-App
2.92
1.02%
-0.03
Handel nachbörslich:
2.92
Schlusskurs vom Vortag:
$2.95
Offen:
$2.9544
24-Stunden-Volumen:
23,686
Relative Volume:
0.02
Marktkapitalisierung:
$5.35M
Einnahmen:
$12.31M
Nettoeinkommen (Verlust:
$-5.08M
KGV:
-3.1064
EPS:
-0.94
Netto-Cashflow:
$-5.20M
1W Leistung:
+2.10%
1M Leistung:
-14.37%
6M Leistung:
+8.96%
1J Leistung:
-37.82%
1-Tages-Spanne:
$2.89
$2.97
1-Wochen-Bereich:
$2.81
$3.04
52-Wochen-Spanne:
$1.75
$9.374
Sonoma Pharmaceuticals Inc Stock (SNOA) Company Profile
Firmenname
Sonoma Pharmaceuticals Inc
Sektor
Telefon
800-759-9305
Adresse
5445 CONESTOGA COURT, SUITE 150, BOULDER, CA
Vergleichen Sie SNOA mit anderen Aktien
| Aktien | Preis | Marktkapitalisierung | Umsatz | Nettogewinn | Free Cashflow | ENV |
|---|---|---|---|---|---|---|
SNOA
Sonoma Pharmaceuticals Inc
|
2.92 | 5.35M | 12.31M | -5.08M | -5.20M | -0.94 |
|
RGC
Regencell Bioscience Holdings Ltd
|
10.36 | 303.95B | 0 | -5.87M | -767.30K | -0.45 |
|
ZTS
Zoetis Inc
|
159.08 | 74.39B | 9.29B | 2.52B | 2.28B | 5.57 |
|
HLN
Haleon Plc Adr
|
10.26 | 48.97B | 14.35B | 1.85B | 0 | 0.4023 |
|
TAK
Takeda Pharmaceutical Co Adr
|
15.42 | 47.39B | 30.08B | 710.16M | 4.45B | 0.2182 |
|
TEVA
Teva Pharmaceutical Industries Ltd Adr
|
17.05 | 20.17B | 16.54B | -1.64B | 749.00M | -1.45 |
Sonoma Pharmaceuticals Inc Aktie (SNOA) Neueste Nachrichten
Global Dental Market Set to Reach USD 19.13 Bn by 2032, Driven by 7.5% CAGR | Coherent Market Insights - newstrail.com
Sonoma Pharmaceuticals Reports Fiscal Year and Fourth Quarter 2025 Financial Results | SNOA Stock News - GuruFocus
Sonoma Pharmaceuticals Reports Fiscal Year and Fourth Quarter 2025 Financial Results - ACCESS Newswire
Sonoma Pharmaceuticals, Inc. SEC 10-K Report - TradingView
SONOMA PHARMACEUTICALS Earnings Preview: Recent $SNOA Insider Trading, Hedge Fund Activity, and More - Nasdaq
Sonoma Pharmaceuticals (NASDAQ:SNOA) Stock Price Passes Above 200-Day Moving Average – Time to Sell? - Defense World
Dental Market Set to Witness Robust Growth Fueled by Aesthetic - openPR.com
Keloid Treatment Market Exclusive Trends Analysis with Forecast to 2034 - openPR.com
Pre-market Movers: NIVF, TRAW, KKR, AGEN... - RTTNews
Hospital Surgical Disinfectants Market Is Booming So Rapidly - openPR.com
Williams-Sonoma, Inc. (NYSE:WSM) Given Consensus Rating of “Hold” by Analysts - Defense World
Scar Treatment Market Is Booming So Rapidly | Merz, Lumenis, Sientra - newstrail.com
Sonoma Pharmaceuticals (NASDAQ:SNOA) Stock Crosses Above 200-Day Moving Average – Time to Sell? - Defense World
Mirum Pharmaceuticals Appoints Doug Sheehy, JD, as Chief Legal Officer - Business Wire
Netflix To $1,220? Here Are 10 Top Analyst Forecasts For Monday - Benzinga
Sonoma Biotherapeutics Appoints Rajesh Krishnan, Ph.D., as Chief Technical Officer - citybiz
Keloid Treatment Market Development Accelerated by Consumer - openPR.com
Pre-market Movers: KTTA, SXTC, GLMD, TCMD... - RTTNews
Sonoma Pharmaceuticals, Inc. to Host Earnings Call - ACCESS Newswire
Checking in on Sonoma Pharmaceuticals Inc (SNOA) after recent insiders movement - knoxdaily.com
A Piece Of The Puzzle Missing From Sonoma Pharmaceuticals, Inc.'s (NASDAQ:SNOA) 35% Share Price Climb - simplywall.st
Press Release Distribution & PR Platform - ACCESS Newswire
Stocks of Sonoma Pharmaceuticals Inc (SNOA) are poised to climb above their peers - Sete News
Sonoma Pharmaceuticals (SNOA) Expands Acne Product Line to UK Re - GuruFocus
Sonoma Pharmaceuticals Inc’s latest rating changes from various analysts - knoxdaily.com
Financial Analysis: Integra Resources Corp (ITRG)’s Ratios Unveil Key Insights - DWinneX
Metric Deep Dive: Understanding Sonoma Pharmaceuticals Inc (SNOA) Through its Ratios - DWinneX
Analyzing SNOA’s price-to-book ratio for the last quarter - uspostnews.com
Crude Oil Falls Over 3%; Philip Morris Earnings Top Views - Benzinga
Dow Jumps Over 1,000 Points; Tesla Shares Rise After Q1 Results - Benzinga
Sonoma Pharmaceuticals Inc (SNOA) Stock: A Year of Declines and Increases - investchronicle.com
Ratio Revelations: Shuttle Pharmaceuticals Holdings Inc (SHPH)’s Financial Metrics in the Spotlight - DWinneX
Financial Snapshot: Analyzing Phio Pharmaceuticals Corp (PHIO)’s Key Ratio Metrics - DWinneX
UK Retail Deal Sparks Early Buying Frenzy in Pharma Stock - The Globe and Mail
Daily Progress: 60 Degrees Pharmaceuticals Inc (SXTP) Drop -15.51, Closing at 2.67 - DWinneX
Why Vertiv Holdings Shares Are Trading Higher By 17%; Here Are 20 Stocks Moving Premarket - Benzinga
Sonoma Pharmaceuticals Poised to Sell Acne Products in UK; Shares Soar Premarket - marketscreener.com
Sonoma Pharmaceuticals (NASDAQ:SNOA) Shares Cross Above 200-Day Moving Average – Here’s Why - Defense World
Sonoma Pharmaceuticals (SNOA) Expands Reach with UK Product Regi - GuruFocus
Major UK Retail Breakthrough: Sonoma's Natural Acne Treatment to Roll Out Across 1,200 Leading Pharmacies - Stock Titan
Brokerages Set Alnylam Pharmaceuticals, Inc. (NASDAQ:ALNY) PT at $315.58 - Defense World
North America Scar Treatment Market Deep Research Report with - openPR.com
NovoCure (NASDAQ:NVCR) vs. Sonoma Pharmaceuticals (NASDAQ:SNOA) Financial Review - Defense World
Rising Trends of Scar Treatment Market in Worldwide | Top most Key - openPR.com
Analyzing Inspira Technologies Oxy B.H.N. (NASDAQ:IINN) and Sonoma Pharmaceuticals (NASDAQ:SNOA) - Defense World
SNOA stock touches 52-week low at $1.84 amid market challenges - Investing.com Australia
SNOA stock touches 52-week low at $1.84 amid market challenges By Investing.com - Investing.com South Africa
Head to Head Survey: DarioHealth (NASDAQ:DRIO) & Sonoma Pharmaceuticals (NASDAQ:SNOA) - Defense World
Delaware passes law designed to stop more Elon Musks from leaving state - Yahoo Finance
Fast-paced Momentum Stock Sonoma Pharmaceuticals (SNOA) Is Still Trading at a Bargain - Yahoo Finance
Sonoma Pharmaceuticals expands agreement with WellSpring By Investing.com - Investing.com Australia
Finanzdaten der Sonoma Pharmaceuticals Inc-Aktie (SNOA)
Umsatz
Nettogewinn
Free Cashflow
ENV
2.01%
0.40%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):